Clinical Trial Update: Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing stem cell transplantation using a reduced-toxicity myeloablative conditioning regimen for high-risk multiple myeloma; the study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Leukemia

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Multiple Myeloma, Plasma Cell Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2014-12-11